Fiona Yin of Saint Island International Patent & Law Offices says patent applicants should consider the Accelerated Examination Procedure for Re-examination as it offers an easier application process ...
uniQure is the owner of Canadian Patent No. 2,737,094 (the Patent). The Patent is directed to a modified Factor IX (FIX) polypeptide involved in blood clot formation. The Patent covers uniQure’s drug ...
Finding that rulings on validity from re-examination proceedings are not dispositive of validity in a district court proceeding, the US Court of Appeals for the Federal Circuit vacated summary ...
There’s no rest for Magma Design Automation’s legal team this holiday season. The Santa Clara, Calif.-based EDA tool provider Wednesday filed a second request with the U.S. Patent and Trademark Office ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Basel, Switzerland, June 25, 2010 - Basilea Pharmaceutica Ltd. (SIX:BSLN) announces that following a request for re-examination from the Applicant Janssen-Cilag International NV (Janssen-Cilag), a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results